☆ 4.6 Article

A phase 2b, dose-selection study evaluating the efficacy and safety of oral ibrexafungerp vs fluconazole in vulvovaginal candidiasis (DOVE)

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)

Get Full Text
Add to Collection

Journal

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 221, Issue 6, Pages 673

Publisher

Elsevier BV
DOI: 10.1016/j.ajog.2019.10.088

Keywords

-

Categories

Obstetrics & Gynecology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.